Formulation and Optimization of Trandolapril Oro-dispersible Tablets using the Quality by Design (QbD) Approach

被引:1
作者
Kumar, Ganesh [1 ]
Bhatt, Meenakshi [2 ]
机构
[1] Coll Pharm, Shivalik Campus, Dehra Dun, Uttrakhand, India
[2] SGRR Univ, Sch Pharmaceut Sci, Dehra Dun, Uttrakhand, India
关键词
Oro-dispersible tablet; crospovidone; microcrystalline cellulose; quality by design; disintegration; friability; PRODUCTS;
D O I
10.2174/1570180819666220429153102
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Introduction This study aims to use a Quality by Design (QbD) approach to formulate and optimize Trandolapriloro-dispersible tablets. The central composite design tool was utilized to assess the scientific understanding of independent input variables and output responses to construct a design space for regulatory flexibility. Oro-dispersible Tablets (ODT) can also be used to deliver drugs directly to the oral mucosa, bypassing first-pass hepatic metabolism and potentially accelerating the process. Methodology The concentrations of super disintegrant and dry compressible binder were selected as independent variables. Disintegration time in seconds and % friability was selected as dependent variables. Polynomial equations were used to predict the quantitative effect of independent variables at various levels on response variables. Results and Discussion The pre-compression parameters suggested that the flow characteristics were quite excellent. All tablets prepared in the above experiments were evaluated for pharmaco-technical properties and found to be within the required limits using the direct compression method. The angle of repose of the dry blends from each formulation batch (F1 to F9) ranged from 29.03 & DEG; to 33.67 & DEG;. All formulation batches had a loose bulk density of 0.31 & PLUSMN; 0.07 to 0.37 & PLUSMN; 0.91 g/cm(3) and a tapped density of 0.41 & PLUSMN; 0.02 to 0.46 & PLUSMN; 0.16 g/cm(3), respectively. The compressibility index was determined to be between 1.65 & PLUSMN; 0.17 to 19.93 & PLUSMN; 0.47 . Hausner's ratio was between 1.14 & PLUSMN; 0.88 to 1.19 & PLUSMN; 0.32. The thickness of the tablets ranged from 2.07 & PLUSMN; 0.54 to 2.52 & PLUSMN; 0.12 mm. The tablets were found to have a hardness of 3.08 & PLUSMN; 0.14 to 3.67 & PLUSMN; 0.41 kg/cm(2). The weight of the tablets prepared ranged from 50 & PLUSMN; 0.09 to 52 & PLUSMN; 0.56 mg on average. Tablet friability was 0.52 & PLUSMN; 0.54 to 0.83 & PLUSMN; 0.10%, and the disintegration time ranged between 27 and 58 seconds. All of these parameters were found under the acceptable limit of pharmacopoeias. The increase of Crospovidone concentration decreased the disintegration time and increased % friability. Whereas increasing the concentration of microcrystalline cellulose increased the disintegration time and decreased the % friability. Contour plots clarified the link between independent and dependent variables. The most cost-effective batch was chosen based on these plots within the desired range because the actual and projected values suggested by the full model were very close to each other; the statistical model is mathematically valid. Conclusion The results showed that the proposed design for developing trandolapriloro-dispersible tablets with optimal properties was effective.
引用
收藏
页码:1194 / 1203
页数:10
相关论文
共 50 条
  • [1] Design and Optimization of Lornoxicam Dispersible Tablets Using Quality by Design (QbD) Approach
    Almotairi, Nawaf
    Mahrous, Gamal M.
    Al-suwayeh, Saleh
    Kazi, Mohsin
    PHARMACEUTICALS, 2022, 15 (12)
  • [2] Quality by design approach for formulation development: A case study of dispersible tablets
    Charoo, Naseem A.
    Shamsher, Areeg A. A.
    Zidan, Ahmed S.
    Rahman, Ziyaur
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 423 (02) : 167 - 178
  • [3] Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets
    Alejandro, Blasco
    Guillermo, Torrado
    Angeles, Pena M.
    PHARMACEUTICALS, 2020, 13 (05)
  • [4] Gamma oryzanol niosomal gel for skin cancer: formulation and optimization using quality by design (QbD) approach
    Harsh S. Shah
    Ankit Gotecha
    Dolly Jetha
    Amarjitsing Rajput
    Aditi Bariya
    Shital Panchal
    Shital Butani
    AAPS Open, 7 (1)
  • [5] Dissolution Rate Enhancement of Entacapone and Formulation of its Oro- Dispersible Tablets: Applying Statistical Design
    Kumar, Mahapatra Anjan
    Murthy, Padala Narasimha
    Sameeraja, Nagampalli Haritha
    Narayan, Palei Narahari
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2016, 50 (04) : 549 - 562
  • [6] Quality by design (QbD) in the formulation and optimization of liquid crystalline nanoparticles (LCNPs): A risk based industrial approach
    Waghule, Tejashree
    Dabholkar, Neha
    Gorantla, Srividya
    Rapalli, Vamshi Krishna
    Saha, Ranendra Narayan
    Singhvi, Gautam
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 141
  • [7] Quality-by-design based development of fast dispersible nimodipine tablets: Formulation attributes and release kinetic assessment
    Akhtar, Hira
    Naqvi, Ghazala Raza
    Zafar, Farya
    Ali, Huma
    Saeed, Rehana
    Parveen, Shaheen
    Alam, Shazia
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 36 (02) : 547 - 556
  • [8] A QbD Approach for the Formulation and Control of Triclabendazole in Uncoated Tablets: From Polymorphs to Drug Formulation
    Muzi, Lucas P.
    Antonio, Marina
    Maggio, Ruben M.
    PHARMACEUTICS, 2024, 16 (12)
  • [9] FORMULATION OF ORODISPERSIBLE TABLETS CONTAINING PARACETAMOL AND THEIR IN VITRO CHARACTERIZATION - A QbD APPROACH
    Muntean, Andrei Catalin
    Negoi, Oana Iuliana
    Rus, Luca Liviu
    Vonica, Andreea Loredana
    Tomuta, Ioan
    FARMACIA, 2020, 68 (03) : 436 - 446
  • [10] APPLICATION OF QUALITY BY DESIGN (QBD) IN FORMULATION DEVELOPMENT OF IMMEDIATE AND EXTENDED RELEASE BILAYERED TABLETS OF DEXTROMETHORPHAN AS A MODEL
    Nadeem, Mohd
    Babu, M. Suresh
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 1 (06): : 439 - 447